Dan L Duncan Comprehensive Cancer Center

Events

Master
Content

Meeting Cancellations, Postponements, Changes

An Up-to-Date List of Oncology Conferences

Note: This list, provided by The Cancer Letter, is current as of March 11. Check the current schedule.

Heading

Past Lectures

Heading

DLDCCC Distinguished Lecture Series

Media Component
Dr. Andy Minn giving his talk on on how interferon signaling and activation of pattern recognition receptors not only can enhance cancer immunotherapy but also limit response, resulting in resistance.
Content

Tuesday, May 7, 2019
Noon – 1 p.m.
Baylor Main – Alkek N315
Andy Minn, M.D., Ph.D.
Associate Professor
Radiation Oncology
University of Pennsylvania
Dr. Minn’s research is interested in gene programs and signaling pathways discovered through unbiased high-dimensional data analysis that regulate cancer metastasis and its resistance to either conventional treatment or immune therapies.

Heading

8th Annual Hereditary Breast & Ovarian Cancer Patient Conference

Content

Saturday, April 6, 2019
9:30 a.m. – 3 p.m.
Baylor College of Medicine Medical Center (NOT Baylor Clinic)
7200 Cambridge
1st floor Alford Education Center
Featuring talks from medical experts related to the healthcare of BRCA mutation carriers. This conference is designed to raise awareness about cancer risks and prevention options for BRCA mutation carriers and their families.

Heading

DLDCCC Distinguished Lecture Series

Content

Tuesday, March 5, 2019
Noon - 1 p.m.
Baylor Main - Alkek, N315
Barbara Andersen, Ph.D.
Distinguished Professor
Department of Psychology
Ohio State University
Dr. Andersen studies biobehavioral aspects of cancer and their implications for disease progression, with work focused on development of interventions for patients at high risk for psychological or behavioral morbidities or premature cancer death.

Heading

SABCS Update at Baylor College of Medicine

Content

Jan. 26, 2019
7 a.m. - 1 p.m.
Baylor Main - Kleberg Auditorium

Heading

Inaugural Symposium CPRIT Proteomic and Metabolomic Facility

Content

Jan. 11, 2019
8 a.m. - 2 p.m.
Baylor Main - Kleberg Auditorium

Heading

“Remodeling makeovers in renal cell carcinoma”

Content

Monday, Jan. 7, 2019
Noon – 1 p.m.
Baylor Main – Alkek N315
Kimryn Rathmell, M.D., Ph.D.
Director, Division of Hematology and Oncology
Cornelius Abernathy Craig Chair, Department of Medicine
Professor of Medicine and Biochemistry
Vanderbilt University Medical Center
Hosted by Dr. Kent Osborne and the Dan L Duncan Comprehensive Cancer Center, this talk will summarize recent findings of epigenetic contributions to genomic instability and endogenous retrovirus gene expression in renal cell carcinoma. These alterations impact the genomic and epigenetic heterogeneity of these tumors, and may alter the response to immunotherapy
 

Heading

San Antonio Breast Cancer Symposium (SABCS)

Media Component
Dr. Kent Osborne giving opening remarks at SABCS.
Content

Dec. 4-8, 2018 marked the San Antonio Breast Cancer Symposium's 41st year with more than 7000 breast oncologists, researchers and advocates. SABCS is the largest annual conference for breast cancer in the world. The Dan L Duncan Comprehensive Cancer Center's Director, Dr. Kent Osborne has been a part of planning this symposium since it's onset.

Heading

“Fueling T cell differentiation in inflammation and cancer” Seminar

Content

Monday, Nov. 12, 2018
Noon – 1 p.m.
BCM Main – Alkek N315
Jeffrey Rathmell, PhD
Cornelius Vanderbilt Professor of Immunobiology
Professor of Pathology, Microbiology, and Immunology
Director, Vanderbilt Center for Immunobiology
Leader, Host-Tumor Interactions Program of the Vanderbilt-Ingram Cancer Center
Associate Director, Institute for Infection, Immunology and Inflammation
Vanderbilt University Medical Center
T cells undergo metabolic reprogramming upon differentiation to gain effector or suppressive functions. This presentation will discuss mechanisms that regulate these metabolic transitions and how metabolic pathways direct gene expression and cellular differentiation in inflammatory diseases and anti-tumor responses.

Heading

DLDCCC Distinguished Lecture Series

Content

Tuesday, Nov. 6, 2018
Noon - 1 p.m.
BCM Main - Alkek, N315
Yves A. DeClerck, M.D.
Professor of Pediatrics and Biochemistry and Molecular Medicine
Keck School of Medicine of USC
Co-leader, Tumor Microenvironment Program, USC-Norris Comprehensive Cancer Center
Associate Director for Education and Training, USC-Norris Comprehensive Cancer Center
University of Southern California
Mesenchymal Stromal Cells: Contributors to Therapeutic Care in Cancer”
The contribution of bone marrow-derived mesenchymal stromal cells to cancer progression has been well recognized over the last decade. This presentation will illustrate—using neuroblastoma as a model—how these cells not only contribute to metastasis to the bone, but also promote therapeutic resistance in primary tumors.

Heading

DLDCCC Distinguished Lecture Series

Content

Tuesday, Nov. 6, 2018
Noon - 1 p.m.
BCM Main - Alkek, N315
Yves A. DeClerck, M.D.
Professor of Pediatrics and Biochemistry and Molecular Medicine
Keck School of Medicine of USC
Co-leader, Tumor Microenvironment Program, USC-Norris Comprehensive Cancer Center
Associate Director for Education and Training, USC-Norris Comprehensive Cancer Center
University of Southern California
Mesenchymal Stromal Cells: Contributors to Therapeutic Care in Cancer”
The contribution of bone marrow-derived mesenchymal stromal cells to cancer progression has been well recognized over the last decade. This presentation will illustrate—using neuroblastoma as a model—how these cells not only contribute to metastasis to the bone, but also promote therapeutic resistance in primary tumors.

Heading

Baylor St. Luke's Medical Center & Dan L Duncan Comprehensive Cancer Center Hematologic Malignancies Symposium

Content

Clonal Hematopoiesis
Myelodysplasia and Acute AML Pathogenesis and Therapy
Saturday, Nov. 3, 2018
12-12:45 p.m. - Poster Session
8 a.m. - 4 p.m. - Presentations
BCM Main - Cullen Auditorium & Rayzor Lounge

Heading

Dan L Duncan Comprehensive Cancer Center

Content

Tuesday, Sept. 11, 2018
Noon - 1 p.m.
BCM Main - Alkek, N315
Dr. Dan Theodorescu
Professor of Surgery
Phase One Foundation Endowed Chair in Oncology
Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai
Translating Cancer Biology into Novel Therapies”
Working on bladder cancer, Dr. Theodorescu is a leading translational cancer researcher. His pioneering application of computational biology led to the discovery of genes that regulate tumor growth and metastasis in bladder and other cancers.

Heading

Helis Medical Research Foundations Cancer Research Lecture Series

Media Component
William G. Kaelin, Jr., M.D. spoke at the 2018 Helis Lecture Series on "New Treatments for Anemia, Ischemia, and Cancer Emerging from Studies of the von Hippel-Lindau Tumor Suppressor Protein".
Content

Topic: “New Treatments for Anemia, Ischemia, and Cancer Emerging from Studies of the von Hippel-Lindau Tumor Suppressor Protein”
Tuesday, May 15, 2018
3 - 4 p.m.
Cullen Auditorium
Speaker: William G. Kaelin, Jr., M.D.
Howard Hughes Medical Institute Investigator
Professor of Medicine, Dana-Farber Cancer Institute and the Brigham and Women’s Hospital, Harvard Medical School